Areas of Focus
- 慢性乙型肝炎和肝细胞肝癌的分子机制
- 单基因遗传性神经系统疾病致病基因的鉴识及功能研究
Work Experience
- 1999年至今 - 中国医学科学院基础医学研究所 - 研究员
- 现任 - 北京生物化学与分子生物学会 - 监事长
- 现任 - 《中华医学遗传学杂志》 - 编委
Academic Background & Achievements
- 1999年 - 生物化学博士: 日本鸟取大学
- 2015年 - 荣获“国家卫生计生有突出贡献中青年专家”称号
Publications
- ADAR1 Stimulation by IFN-a Downregulates the Expression of MAVS via RNA Editing to Regulate the Anti-HBV Response., 刘英, 2021
- PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by influencing synaptic function in the primary motor cortex of rats., 刘英, 2019
- Genetic Variation in STAT4 Predicts Response to Interferon-a Therapy for Hepatitis B e Antigen-Positive Chronic Hepatitis B., 刘英, 2016
- A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations., 刘英, 2014
- A missense polymorphism in ATF6 gene is associated with susceptibility to hepatocellular carcinoma probably by altering ATF6 level., 刘英, 2014
- Polymorphisms in the VEGFA promoter are associated with susceptibility to hepatocellular carcinoma by altering promoter activity., 刘英, 2013
- Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis., 刘英, 2012
- Polymorphisms in ADAR1 gene affect response to interferon alpha based therapy for chronic hepatitis B in Han Chinese., 刘英, 2012
- Evaluation of susceptibility locus for response to interferon-α based therapy in chronic hepatitis B patients in Chinese., 刘英, 2012
Awards
- 2015年: 国家卫生计生有突出贡献中青年专家